Literature DB >> 15111183

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance.

Toshihiro Osaki1, Akira Nagashima, Takashi Yoshimatsu, Sosuke Yamada, Kosei Yasumoto.   

Abstract

BACKGROUND: A tumor of any size that invades the visceral pleura is classified in the T2 category; however, the definition of the visceral pleural involvement has remained somewhat ambiguous. It is unclear whether the T2 category includes the p2 status alone or incorporates the extent of the p1 status.
METHODS: We retrospectively analyzed the survival of 474 patients with T1 and T2 nonsmall cell lung cancer to evaluate the influence of the degree of visceral pleural involvement (p0, p1, and p2) on the prognosis and to clarify the definition of the visceral pleural involvement.
RESULTS: The 5-year survival rates according to the degree of visceral pleural involvement were 68.0% in p0 (n = 345), 43.9% in p1 (n = 110), and 54.9% in p2 (n = 19; p0 versus p1, p = 0.0004; p0 versus p2, p = 0.013; and p1 versus p2, p = 0.61). The degree of visceral pleural involvement (p0 versus p1/p2) was a significant independent prognostic factor from tumor size and lymph node involvement, by multivariate analysis (relative risk = 1.47, p = 0.033). The prognosis of pN0 patients with p1 and tumor size 3 cm or less was significantly poorer than that of those with p0 and tumor size 3 cm or less (p = 0.0004), and the prognosis of patients with p1 and tumor size more than 3 cm was significantly poorer than that of those with p0 and tumor size more than 3 cm (p = 0.024).
CONCLUSIONS: The degree of visceral pleural involvement (p0 versus p1/p2) is an important component of the lung cancer staging system. Tumors with p1 and p2 status should be regarded as representing visceral pleural involvement and T2 disease.

Entities:  

Mesh:

Year:  2004        PMID: 15111183     DOI: 10.1016/j.athoracsur.2003.10.058

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.

Authors:  Jun-Ichi Nitadori; Christos Colovos; Kyuichi Kadota; Camelia S Sima; Inderpal S Sarkaria; Nabil P Rizk; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

2.  Visceral pleural invasion in lung adenocarcinoma ≤3 cm with ground-glass opacity: a clinical, pathological and radiological study.

Authors:  Li-Lan Zhao; Hui-Kang Xie; Li-Ping Zhang; Jun-Yan Zha; Fang-Yu Zhou; Ge-Ning Jiang; Chang Chen
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Previous tumour as a prognostic factor in stage I non-small cell lung cancer.

Authors:  Angel López-Encuentra; Agustín Gómez de la Cámara; Ramón Rami-Porta; José Luis Duque-Medina; José Luis Martín de Nicolás; Javier Sayas
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

4.  [New TNM classification of malignant lung tumours].

Authors:  J Wohlschläger; C Wittekind; D Theegarten
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

5.  Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden.

Authors:  Elliot L Servais; Christos Colovos; Stefan S Kachala; Prasad S Adusumilli
Journal:  Curr Protoc Pharmacol       Date:  2011-09

6.  Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.

Authors:  Juan J Fibla; Stephen D Cassivi; Alessandro Brunelli; Paul A Decker; Mark S Allen; Gail E Darling; Rodney J Landreneau; Joe B Putnam
Journal:  Lung Cancer       Date:  2012-10-03       Impact factor: 5.705

7.  Invasion of the inner and outer layers of the visceral pleura in pT1 size lung adenocarcinoma measuring ≤ 3 cm: correlation with malignant aggressiveness and prognosis.

Authors:  Makoto Hamasaki; Fumiaki Kato; Kaori Koga; Hiroyuki Hayashi; Mikiko Aoki; Yoshihiro Miyake; Akinori Iwasaki; Kazuki Nabeshima
Journal:  Virchows Arch       Date:  2012-09-22       Impact factor: 4.064

8.  A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancer.

Authors:  Arne Warth; Thomas Muley; Esther Herpel; Joachim Pfannschmidt; Hans Hoffmann; Hendrik Dienemann; Peter Schirmacher; Philipp A Schnabel
Journal:  Pathol Oncol Res       Date:  2010-03       Impact factor: 3.201

9.  A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer.

Authors:  Sinead Cuffe; Abderrahmane Bourredjem; Stephen Graziano; Jean-Pierre Pignon; Caroline Domerg; Monia Ezzalfani; Lesley Seymour; Elizabeth Strevel; Ronald Burkes; Marzia Capelletti; Pasi A Jänne; Ming-Sound Tsao; Frances A Shepherd
Journal:  J Thorac Oncol       Date:  2012-06       Impact factor: 15.609

10.  Pathological evaluation of the visceral pleura in the radical pleurectomy/decortication for malignant pleural mesothelioma patients.

Authors:  Masashi Kobayashi; Hironori Ishibashi; Chihiro Takasaki; Sachiko Imai; Susumu Kirimura; Kenichi Okubo
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.